The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity
Ali Hmedat, Jessica B. Doondeea, Daniel V. Ebner, Stephan M. Feller, Marc Lewitzky
This paper shows that Dasatinib and glucocorticoids work together to kill tongue squamous cell carcinoma cells by reducing MET kinase activity and inducing cell cycle arrest and senescence.
Cell Communication and Signaling · Jun 19, 2025Peer-reviewedCancer Biology